The Latest in Lymphoma & Plasma Cell Disorders

NORD publishes physician guide to CTCL

October 28, 2016

Genetic screening for CLL premature, speaker says

October 27, 2016

FDA grants drug orphan designation for CTCL

October 26, 2016

No longer a hand-me-down approach to WM

October 25, 2016

Compound could treat a range of blood cancers

October 25, 2016

Serious AEs reported too late in lymphoma trial

October 24, 2016

Lymphoma & Plasma Cell Disorders

FDA issues warning about radiation therapy devices

October 21, 2016

Single-cell findings could inform CLL treatment

October 20, 2016

Burden of cancer varies by cancer type, race

October 20, 2016

Doc provides perspective on CAR T-cell therapy in CLL

October 19, 2016

CHMP recommends conditional approval of drug for CLL

October 15, 2016

Supportive care isn’t palliative care, speaker says

October 8, 2016

Speaker outlines importance of cell of origin in DLBCL

October 7, 2016

Drug granted conditional approval to treat CLL in Canada

October 6, 2016

Enzyme may be therapeutic target for NHL

October 4, 2016